Belite Bio Presented Interim Results of LBS-008 Phase 1b/2 Study in Adolescent STGD1 at ARVO Annual Meeting 2022
LBS-008 showed an acceptable safety profile in adolescent Stargardt disease subjectsA trend for stabilized or improved visual acuity was observedObserved adverse events were anticipated based on the... | May 5, 2022
Source: marketscreener.com